Mesa Laboratories (MLAB) Cash & Current Investments (2010 - 2026)

Mesa Laboratories has reported Cash & Current Investments for 16 years, with the latest figure at $30.5 million in Q4 2025.

• Quarterly Cash & Current Investments rose 6.32% year-over-year to $30.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.5 million (up 6.32% YoY) and the FY2025 annual result came in at $29.1 million, down 3.45% from the prior year.
• Cash & Current Investments climbed to $30.5 million in Q4 2025 per MLAB's latest filing, from $21.9 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $278.3 million in Q3 2021 and troughed at $21.9 million in Q3 2025.
• A 5-year average of $69.1 million and a median of $32.1 million in 2023 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2021 and 2022: Cash & Current Investments surged 224.24% in 2021, then tumbled 87.36% in 2022.
• Over 5 years, Cash & Current Investments stood at $51.7 million in 2021, then tumbled by 46.23% to $27.8 million in 2022, then increased by 9.22% to $30.4 million in 2023, then fell by 5.62% to $28.7 million in 2024, then advanced by 6.32% to $30.5 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $30.5 million, $21.9 million, and $23.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.